IBA works with Belgium on first proton therapy center

By News Release
0  Votes

IBA, a provider of proton therapy solutions for the treatment of cancer, has announced that building works have begun on the Proton Therapy Center ParTICLe – Belgium’s first center for proton therapy. ParTICLe, short for Particle Therapy Interuniversity Center Leuven, is a clinical and scientific collaboration between five university hospitals.

Currently, Belgian patients eligible for proton therapy must travel abroad for treatment; usually to Germany, Switzerland or France. It is expected that Belgian patients will now be able to receive proton therapy in their home country by mid-2019.

Olivier Legrain, chief operational officer at IBA, commented: “This first proton therapy center in Belgium is a significant milestone for the country and our partners in this project. We look forward to establishing a leading research collaboration with ParTICLe and its specialists, as well as providing high quality training programs for physicians and medical staff.”

Prof. Dr. Karin Haustermans, head of the Department of Radiation Oncology in UZ Leuven, said: "Despite the enormous technical advances in radiation for cancer treatment, we still see too many patients who relapse or have permanent side effects. Sometimes when healthy radiation-sensitive tissues are too close to the tumor; it is almost impossible to irradiate them without compromising the quality of life of the patient. Proton therapy provides more protection to healthy tissue, and reduces the risk of secondary cancer caused by the radiation itself."

Prof. Dr. Marc Decramer, managing director of UZ Leuven added: "We see it as our responsibility to take the lead in this project. In 1928, we built the first Cancer Institute in Leuven with the support of the Belgian population. Today, we go one step further; we invest across language barriers and collaborate with the other university hospitals and regional hospitals on high-tech cancer therapy. Collaboration is an evolution that you see everywhere in the clinical and scientific world. Sharing financial input and scientific knowledge is the best way to shift boundaries."

Back To Top

IBA works with Belgium on first proton therapy center.  Appl Rad Oncol. 

By News Release| May 03, 2017
Categories:  Technologies|Section

About the Author

News Release

News Release


Copyright © Anderson Publishing, Ltd